News

AI-powered platform will allow clinical trial sites to connect directly with patient EHRs.

AARDEX MEMS AS and MEMS Mobile technology will be integrated with Mevia’s Medose dispenser.

Nathalie Dubois-Stringfellow, Sangamo’s chief development officer discusses the company's diverse clinical programs, strategic collaborations, including a partnership with Pfizer, and the crucial role of patient safety.

DIA President and Global Chief Executive provides the highlights for this year’s meeting being held in Boston at the end of June.

First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.

What does the future of digital health look like?

Software and biometrics services provider announces expanded AI and ML capabilities.

Newly released book edited by Matt Reaney, (PhD, CPsychol, CSci, MSc), head, science and analytics, PCS, at IQVIA focuses on patient experience data with all levels of clinical research in mind.

Veeva R&D Business Consulting will provide operating model design, data governance, and change management services.

Using uMotif eCOA/ePRO data capture app, significant ethnic disparities in pain recognition and management are revealed.

Latest number of oncology clinical trials from ClinicalTrials.gov.

Under new agreement, companies can receive biometric data services from Quanticate coupled with global resourcing solutions from KPS Life.

Caregiver-completed pediatric survey was developed in 12 different languages, including new translated versions to ensure comparable measures.

Recent study results highlight need for new metrics in ECOG scoring to mitigate variability.

Benchmark survey provides timely insights into clinical trial sites' relationships with sponsors and CROs post-pandemic.

Partnership will enable international sponsors to deliver patient payments globally, including China.

This latest guidance provides a 15-year update on the recommendations, including the use of CGM devices.

Facility upgrade will support clinical supply demand for CGT development.

Agency hopes to update and improve its advisory committee composition and operations—to help FDA scientists “get the best advice possible.”

Harsha K. Rajasimha, PhD, founder and executive chairman, IndoUSrare, provides the OCT audience insights into better achieving DEIA clinical trials.

In this Q&A, Craig Lipset offers additional insights following the announcement that CVS will be closing its clinical trial services business by the end of the year.

Allucent partners with THREAD to launch Allucent Patient Direct Trials, a DCT offering focused on small and mid-sized biotech companies.

New solution delivers simplified questionnaire licensing and localizations, streamlined device logistics, and improved data integrity.

UCB will adopt Veeva ePRO and Veeva eConsent.

New capability added to VIDA Intelligence Platform will streamline quality-controlled data curation.

In this Q&A, John Kastelein, MD, founder and chief scientific officer, NewAmsterdam Pharma, discusses the challenges and opportunities within the cardiovascular field, exploring the current landscape for lipid-lowering therapies and the unique potential advantages of CETP inhibitors.

Senior leaders gather to share insights on the increased investment in real-world data to boost the quality and efficiency of drug development—as the industry begins to more widely embrace evidence of proven outcomes in aiding approaches in clinical trial design, patient engagement, regulatory decision-making, and other areas.

Latest enhancements will optimize Omnichannel capabilities for ROI reporting.